Journal
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
Volume 2, Issue 2, Pages 356-365Publisher
AMER SOC NEPHROLOGY
DOI: 10.2215/CJN.03280906
Keywords
-
Categories
Funding
- NIDDK NIH HHS [DK56223, DK62324, DK58413] Funding Source: Medline
Ask authors/readers for more resources
Current strategies to limit the extent of injury in acute renal failure are based on extensive studies that identified cellular and molecular mechanisms of acute kidney injury. Despite successes in various animal models, translation to human studies has failed or studies are inconclusive. This review describes past failures and barriers to successful clinical trials. It also focuses on promising preclinical studies using novel compounds that currently are in or close to human investigation. Implementation of previous or novel compounds in well-designed clinical trials provides hope for the successful treatment of this devastating disorder.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available